ArticleLiver cancer2024

Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT.

Richard S Finn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.